News Releases

NEWS RELEASES

GWG Holdings and The Beneficient Company Announce Significant Expansion of Strategic Relationship
Accelerates GWG’s growth, financial capability and diversification Accelerates BEN’s efforts to build the most comprehensive and innovative liquidity provider for alternative asset investors   BEN and certain of its founders to acquire all of Jon and Steven Sabes’ Interest in GWG Holdings GWG CEO
GWG Holdings Announces New Life Expectancy Methodology
Results from Life Expectancy Providers Announced Updates and Changes Life Expectancy tables Significantly Improves Actual-to-Expected Predictive Power   Implementation Results in a Non-Cash, Non-Recurring Charge of $84 million in Q4 2018 MINNEAPOLIS, April 16, 2019 (GLOBE NEWSWIRE) -- GWG Holdings,
Life Epigenetics CEO Jon Sabes to Present at ReFocus Conference 2019 on March 11
MINNEAPOLIS, March 07, 2019 (GLOBE NEWSWIRE) -- Life Epigenetics , a biotechnology company that discovers, quantifies and commercializes epigenetic signatures for use in the longevity, clinical research, pharmaceutical, and nutraceutical markets, announced that its Chief Executive Officer Jon Sabes
GWG Holdings and The Beneficient Company Complete Their Transaction
MINNEAPOLIS , Dec. 28, 2018 (GLOBE NEWSWIRE) -- GWG Holdings , Inc. (Nasdaq: GWGH ) reported today that it has completed its strategic transaction with The Beneficient Company Group, L.P. (BEN) and other parties. As a result of the final closing, GWGH holds 40,505,279 common units of BEN and a $193
GWG Holdings Endorses Federal Legislation Allowing Seniors to Use Life Insurance Proceeds for Long-Term Care Costs Tax-Free
Potential Law Would Save Billions for Taxpayers, Improve Quality of Life for Millions of Seniors Minneapolis, Dec. 13, 2018 (GLOBE NEWSWIRE) -- GWG Holdings (NASDAQ:GWGH) announced its endorsement of a new piece of federal legislation that, for the first time, would enable seniors to sell life
GWG Holdings Clears Final Regulatory Hurdle for Transaction with The Beneficient Company
MINNEAPOLIS , Dec. 06, 2018 (GLOBE NEWSWIRE) -- GWG Holdings , Inc. (Nasdaq: GWGH ) announced today that it has received clearance from the Securities and Exchange Commission ( SEC ) to file with the SEC and mail to its stockholders a definitive Information Statement on Schedule 14C relating to its
GWG Holdings Reports Results for the Third Quarter Ended September 30, 2018
GWGH Announces share repurchase program MINNEAPOLIS , Nov. 19, 2018 (GLOBE NEWSWIRE) -- GWG Holdings, Inc. (Nasdaq:GWGH), a leading provider of liquidity to consumers owning life insurance policies, an owner of a portfolio of alternative assets, and the developer of epigenetic technology for the
GWG Holdings Reschedules Third Quarter 2018 Filing, Earnings Release and Webcast
MINNEAPOLIS , Nov. 14, 2018 (GLOBE NEWSWIRE) -- GWG Holdings, Inc. (Nasdaq: GWGH), a leading provider of liquidity to consumers owning life insurance policies, an owner of a portfolio of alternative assets, and the developer of epigenetic technology for the life insurance industry, announced that
GWG Holdings Announces New Date for Third Quarter 2018 Earnings Release and Webcast
MINNEAPOLIS , Nov. 12, 2018 (GLOBE NEWSWIRE) -- GWG Holdings, Inc. (Nasdaq:GWGH), a leading provider of liquidity to consumers owning life insurance policies, an owner of a portfolio of alternative assets, and the developer of epigenetic technology for the life insurance industry, announced that
GWG Holdings to Report Third Quarter 2018 Financial Results on November 13, 2018
MINNEAPOLIS , Oct. 30, 2018 (GLOBE NEWSWIRE) -- GWG Holdings, Inc. (Nasdaq:GWGH), the parent company of GWG Life, Life Epigenetics and YouSurance, subsidiaries that are transforming the alternative asset and life insurance industries through innovative products and services, announced that it will